ArticleApplied biochemistry and biotechnology2026
Green Synthesis and Characterization of SiO
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Silica nanoparticles (SiO₂ NPs) are versatile nanomaterials with tunable physicochemical properties and excellent biocompatibility, making them suitable for biomedical applications. In this study, a green synthesis approach was employed using Origanum majorana leaf extract as a natural reducing and stabilizing agent to fabricate biofunctionalized SiO₂ nanoparticles. The novelty of this work lies in utilizing a phytochemically rich yet underexplored plant source for synthesizing silica nanoparticles and systematically evaluating their multifunctional biological properties. The synthesized nanoparticles were characterized using UV-Vis spectroscopy, FTIR, XRD, FESEM, EDX, and DLS analyses, confirming the formation of amorphous, high-purity SiO₂ nanoparticles with Si-O-Si and Si-OH functional groups. FESEM analysis revealed particle sizes of 50-200 nm, while DLS indicated a hydrodynamic diameter of 298.3 nm (PDI = 0.496). The nanoparticles exhibited significant antioxidant activity (96.7% DPPH scavenging at 10 µg/mL), concentration-dependent antimicrobial effects, notable anti-inflammatory activity (IC₅₀ = 165 µL), and moderate cytotoxicity against L929 fibroblast cells (IC₅₀ = 112.06 µg/mL). This study presents an eco-friendly strategy for producing biofunctionalized silica nanoparticles with promising applications in nanomedicine and antimicrobial therapy.
Indexed as
Identifiers
42423873What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.